Last week, Dr. Rohini Handa presented a ca... more»Last week, Dr. Rohini Handa presented a case challenge about a patient who presented with purpura and opened up the forum to interpretation. You gave us your responses and this week, we bring you the evaluation from our expert. In this article, Dr. Rohini Handa provides the right responses. «less
Oct 13, 2021
In this case challenge, Dr Rohini Handa pr... more»In this case challenge, Dr Rohini Handa presents a new case open for interpretation. Here, he describes a patient reporting with arthralgias and skin rash, findings from physical examinations and investigations and quizzes doctors on diagnosis and strategies that can be used to treat the patient. «less
Oct 06, 2021
Should patients who suffer from comorbidit... more»Should patients who suffer from comorbidities like rheumatic diseases be vaccinated? Read the case study below and answer the questions that follow. Our expert, Dr Rohini Handa will evaluate your answers and provide the correct responses in the next part. «less
May 31, 2021
Dr. Rohini Handa answers questions on the ... more»Dr. Rohini Handa answers questions on the various drug updates and developments that have expanded the scope of rheumatology practice in the last decade. Discussed here are DMARDs and other drugs used in the treatment protocol for rheumatic arthritis, lupus, and ankylosing spondylitis. «less
Feb 18, 2021
Dr. Rohini Handa explains the role of low-... more»Dr. Rohini Handa explains the role of low-dose and high-dose steroids in Rheumatoid Arthritis (RA), types of corticosteroids and when to use them in established RA, and useful facts for clinicians to use steroids in resource-constrained settings. «less
Jul 01, 2020
Dr. Rohini Handa, a noted Rheumatologist f... more»Dr. Rohini Handa, a noted Rheumatologist from Delhi with rich experience in his field, has tried to clarify the impact of arthritis and the various disease modifying drugs in this article. He also mentions that it is incumbent upon all the doctors to reassure and give hope to the patients. «less
Apr 08, 2020
The year 2019 has been an exciting one for... more»The year 2019 has been an exciting one for Rheumatology as the gap between the bench and bedside narrows slowly but surely! Here, Dr. Rohini Handa reviews the major disease classification criteria updates, notable drug approvals, and immune checkpoint inhibitor related rheumatic diseases. «less
Dec 31, 2019
Dr. Rohini Handa explains that while gout ... more»Dr. Rohini Handa explains that while gout is well understood, it is often a poorly managed condition, and much like handling flares among patients, it is also important to include another aspect of management that is often overlooked- prophylactic therapy. «less
Jun 06, 2019
In our Sunday Series, from our archives, w... more»In our Sunday Series, from our archives, we bring to you an article by Dr. Rohini Handa, a noted Rheumatologist who explains in detail about the clinical presentation of gout and the interesting myths, facts, and science surrounding the disease. «less
Nov 11, 2018
